High blood pressure in early pregnancy raises risk of birth defects, irrespective of medication
October 18, 2011 in Obstetrics & gynaecology
Women with high blood pressure (hypertension) in the early stages of pregnancy are more likely to have babies with birth defects, irrespective of commonly prescribed medicines for their condition, finds new research published in the British Medical Journal today.
The finding suggests that it is the underlying hypertension, rather than the use of antihypertensive drugs in early pregnancy, that increases the risk of birth defects.
Angiotensin-converting enzyme (ACE) inhibitors are a type of antihypertensive medication commonly prescribed to tackle hypertension. It is already known that they have a toxic effect on fetuses in the second or third trimesters, but their effects on a fetus during the mother's first trimester is still unclear.
So researchers led by Dr De-Kun Li of the Kaiser Foundation Research Institute in California, set out to see if there was an association between using ACE inhibitors during a woman's first trimester and birth defects.
They studied data on 465,754 mother-infant pairs from the Kaiser Permanente Northern Californian region between 1995 and 2008. Data was also available on which medications had been prescribed and dispensed to these women.
Analysis showed that women who used ACE inhibitors in their first trimester were more likely to have a baby with some form of birth defect compared with women who did not have hypertension or who had not used any form of antihypertensive medication.
However, a similar elevated risk was found among women who used other antihypertensive drugs and those with hypertension who did not take any antihypertensive medication.
The researchers conclude: "Our finding suggests that it is likely the underlying hypertension rather than use of antihypertensive drugs in the first trimester that increases the risk of birth defects in offspring."
In an accompanying editorial, Professor Allen Mitchell from Boston University says that - based on the available studies - it would appear reasonable to conclude that first-trimester exposure to ACE inhibitors poses no greater risk of birth defects than other antihiypertensives, and that it is the underlying hypertension that places the fetus at risk.
He believes that, while clinicians must certainly identify and control hypertension, particularly in pregnancy, "we have much to learn about how hypertension can cause birth defects."
Provided by
British Medical Journal
-
Widespread use of medications among pregnant women reported
Apr 25, 2011 |
not rated yet |
0
-
No link between antidepressants and birth defects
May 22, 2008 |
not rated yet |
0
-
Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects
May 17, 2011 |
not rated yet |
0
-
Proton-pump inhibitors and birth defects -- some reassurances, but more needed warns epidemiologist
Nov 24, 2010 |
not rated yet |
0
-
Use of certain antiviral drugs during pregnancy not linked with higher risk of major birth defects
Aug 24, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Electric field between parallel plate capacitor
1 hour ago
-
Why angle of projectile has 2 solutions?
1 hour ago
-
How much negative charge do I accumulate by touching the earth?
3 hours ago
-
Indeterminism in Classical Physics
8 hours ago
-
Current in two wires
9 hours ago
-
understanding the dipole model for Rayleigh scattering
11 hours ago
- More from Physics Forums - Classical Physics
More news stories
Bulletin provides guidelines for second-trimester abortion
(HealthDay)—New evidence-based guidelines provide guidance on medical and surgical methods for second-trimester abortion and management of associated complications, according to a practice bulletin published ...
Obstetrics & gynaecology
2 hours ago |
not rated yet |
0
ACOG: Hormone therapy not recommended to prevent CHD
(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published ...
Obstetrics & gynaecology
3 hours ago |
not rated yet |
0
Iodine deficiency during pregnancy may adversely affect children's mental development
A study of around 1,000 UK mothers and their children, published in The Lancet, has revealed that iodine deficiency in pregnancy may have an adverse effect on children's mental development. The research raises concerns that t ...
Obstetrics & gynaecology
May 21, 2013 |
not rated yet |
0
72 percent of pregnant women experience constipation and other bowel problems
Nearly three out of four pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found.
Obstetrics & gynaecology
May 20, 2013 |
not rated yet |
0
Women's reproductive ability may be related to immune system status
New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.
Obstetrics & gynaecology
May 17, 2013 |
not rated yet |
0
|
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
FDA warns of infections tied to Tennessee pharmacy
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Pollen count apps for smartphones are nothing to sneeze at
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...